NDC 76336-080

Lysodren

Mitotane

Lysodren is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Hra Pharma Rare Diseases. The primary component is Mitotane.

Product ID76336-080_73a3f0f8-bc4e-4b27-bcb8-2fb4873652f6
NDC76336-080
Product TypeHuman Prescription Drug
Proprietary NameLysodren
Generic NameMitotane
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-01-06
Marketing CategoryNDA / NDA
Application NumberNDA016885
Labeler NameHRA Pharma Rare Diseases
Substance NameMITOTANE
Active Ingredient Strength500 mg/1
Pharm ClassesCytochrome P450 3A4 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 76336-080-60

1 BOTTLE in 1 CARTON (76336-080-60) > 100 TABLET in 1 BOTTLE
Marketing Start Date2009-01-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 76336-080-60 [76336008060]

Lysodren TABLET
Marketing CategoryNDA
Application NumberNDA016885
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-01-06

Drug Details

Active Ingredients

IngredientStrength
MITOTANE500 mg/1

OpenFDA Data

SPL SET ID:f0cd76e9-460c-450e-b094-172e636f340a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 207373
  • 197988
  • Pharmacological Class

    • Cytochrome P450 3A4 Inducers [MoA]

    NDC Crossover Matching brand name "Lysodren" or generic name "Mitotane"

    NDCBrand NameGeneric Name
    0015-3080LYSODRENMITOTANE
    76336-080Lysodrenmitotane

    Trademark Results [Lysodren]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    LYSODREN
    LYSODREN
    73358100 1243390 Live/Registered
    Bristol-Myers Company
    1982-04-05
    LYSODREN
    LYSODREN
    73156066 1099245 Live/Registered
    CALBIOCHEM-BEHRING CORP.
    1978-01-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.